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Summary
 
Interleukin (IL)-1 is a major mediator of inflammation and exerts pleiotropic effects on the
neuro-immuno-endocrine system. To elucidate pathophysiological roles of IL-1, we have first
produced IL-1
 
a
 
/
 
b
 
 doubly deficient (KO) mice together with mice deficient in either the IL-1
 
a
 
,
IL-1
 
b
 
, or IL-1 receptor antagonist (IL-1ra) genes. These mice were born healthy, and their
growth was normal except for IL-1ra KO mice, which showed growth retardation after wean-
ing. Fever development upon injection with turpentine was suppressed in IL-1
 
b
 
 as well as IL-
1
 
a
 
/
 
b
 
 KO mice, but not in IL-1
 
a
 
 KO mice, whereas IL-1ra KO mice showed an elevated
response. At this time, expression of IL-1
 
b
 
 mRNA in the diencephalon decreased 1.5-fold in
IL-1
 
a
 
 KO mice, whereas expression of IL-1
 
a
 
 mRNA decreased 
 
.
 
30-fold in IL-1
 
b
 
 KO mice,
suggesting mutual induction between IL-1
 
a
 
 and IL-1
 
b
 
. This mutual induction was also sug-
gested in peritoneal macrophages stimulated with lipopolysaccharide in vitro. In IL-1
 
b
 
 KO
mice treated with turpentine, the induction of cyclooxygenase-2 (EC 1.14.99.1) in the dien-
cephalon was suppressed, whereas it was enhanced in IL-1ra KO mice. We also found that glu-
cocorticoid induction 8 h after turpentine treatment was suppressed in IL-1
 
b
 
 but not IL-1
 
a
 
KO mice. These observations suggest that IL-1
 
b
 
 but not IL-1
 
a
 
 is crucial in febrile and neuro-
immuno-endocrine responses, and that this is because IL-1
 
a
 
 expression in the brain is depen-
dent on IL-1
 
b
 
. The importance of IL-1ra both in normal physiology and under stress is also
suggested.
 
I
 
nterleukin (IL)-1 is a proinflammatory cytokine which
plays an important role in host responses to inflammation
and infection (for a review, see references 1–3). IL-1 has
pleiotropic activities, as it had been identified originally as
an endogenous pyrogen, lymphocyte-activating factor, he-
mopoietin-1, and osteoclast-activating factor (4). IL-1 con-
sists of two molecular species, IL-1
 
a
 
 and IL-1
 
b
 
, which are
derived from two distinct genes 50 kb apart on chromo-
some 2 of the mouse genome (5, 6). Although the amino
acid sequence homology of these molecules is only 25%
(4), both molecules exert similar but not completely over-
lapping biological activities through the IL-1 type I recep-
tor (IL-1RI)
 
1
 
 (7). Although an IL-1 type II receptor (IL-
1RII) is also present, this receptor is not considered to be
involved in signal transduction, but rather plays a regula-
tory role as a decoy (8). In addition, another member of the
IL-1 gene family, IL-1 receptor antagonist (IL-1ra), binds
IL-1 receptors without exerting agonistic activity (9, 10).
Three isoforms of IL-1ra protein are synthesized by alter-
native splicing from a single gene; one is a secreted form
with a signal peptide (sIL-1ra), and the other two exist in-
tracellularly (icIL-1raI and icIL-1raII) (11, 12). These three
isoforms can inhibit IL-1 activities.
Pathophysiological roles of IL-1 were suggested in in-
flammation, acute phase responses, host defense against
bacterial and viral infection, activation of the immune sys-
 
1
 
Abbreviations used in this paper:
 
 ACTH, adrenocorticotropic hormone;
COX, cyclooxygenase; CRH, corticotropin-releasing hormone; DT,
diphtheria toxin A fragment gene; ES, embryonic stem; HPA, hypotha-
 
lamic-pituitary-adrenal; IL-1RI and IL-1RII, IL-1 type I and II receptors;
IL-1ra, IL-1 receptor antagonist; KO, knockout; PEC, peritoneal exudate
cells; PGK, phosphoglycerate kinase.
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tem including thymocyte maturation and T helper 2 cell
proliferation, bone metabolism including osteoclast activa-
tion and secretion of metalloproteases, fever development,
and activation of the hypothalamic-pituitary-adrenal (HPA)
axis (1, 2). Roles in the neuro-immuno-endocrine system
are especially worth noting, since they are important in main-
taining homeostasis of the body and controlling the im-
mune system from the central nervous system.
To date, many investigators have made efforts to eluci-
date the roles of IL-1 in the brain. In this connection, it
was shown that both IL-1
 
a
 
 and IL-1
 
b
 
 could induce fever
development and that administration of neutralizing anti-
bodies against IL-1
 
b
 
 inhibited bacterial LPS–induced fever
development (13, 14). Recently, mice deficient in the IL-1
 
b
 
gene were produced, and Kozak et al. (15) reported that
the febrile response to LPS was reduced in these mice. In
contrast, Alheim et al. (16) reported that IL-1
 
b
 
 knockout
(KO) mice were hyperresponsive to LPS-induced fever de-
velopment. The reason for this discrepancy is not com-
pletely clear at present, although the authors suggested the
use of LPS from different bacterial strains in the experi-
ments. Turpentine-induced fever was also examined using
IL-1
 
b
 
 KO mice (17) and IL-1RI KO mice (18). These
studies suggest that endogenous IL-1
 
b
 
 plays an important
role in controlling the febrile response of an animal after lo-
cal inflammation. However, why IL-1
 
b
 
 deficiency is enough
to suppress fever development is not clear, since IL-1
 
a
 
 and
IL-1
 
b
 
 are both produced in the inflammation and both IL-1
species can induce febrile responses.
It has been shown that inflammation, tissue damage, or
infection affect serum glucocorticoid levels (19). Inflamma-
tory cytokines such as IL-1, IL-6, and TNF-
 
a
 
 are sug-
gested to be involved in this activation through the so-
called HPA axis (20, 21); these cytokines stimulate the
hypothalamus to release corticotropin-releasing hormone
(CRH), which then induces secretion of corticotropin
(adrenocorticotropic hormone; ACTH) from the pituitary
and corticosterone from the adrenal cortex. Both LPS and
turpentine, which cause systemic and local inflammation in
experimental animals, respectively, enhance corticosterone
secretion through activation of the HPA axis (22, 23). Al-
though it was suspected that IL-1 was the major mediator
in controlling the HPA axis under such stress (20, 22, 24), a
recent study failed to show effects of IL-1
 
b
 
 deficiency on
the induction of corticosterone after treatment with tur-
pentine (25). These results suggest two possibilities, either
that IL-1 is not involved in the activation of the HPA axis,
at least at 2 h after turpentine treatment, or that IL-1
 
a
 
compensates for the IL-1
 
b
 
 deficiency.
To clarify the roles for each member of the IL-1 gene
family in febrile and neuro-immuno-endocrine responses,
we produced KO mice carrying a null mutation either in
IL-1
 
a
 
, IL-1
 
b
 
, or IL-1ra genes. We also have been the first
to succeed in producing IL-1
 
a
 
/
 
b
 
 double-KO mice by suc-
cessive homologous recombinations in an embryonic stem
(ES) cell.
 
2
 
 Using these KO mice, we studied the effects of
complete deficiency of IL-1 as well as deficiency of one of
these molecules on normal physiology and stress responses
induced by turpentine.
 
Materials and Methods
 
Construction of IL-1
 
a
 
, IL-1
 
b
 
, and IL-1ra Targeting Vectors.
 
IL-
1
 
a
 
, IL-1
 
b
 
, and IL-1ra genomic clones were isolated from mouse
129 genomic phage libraries either from Dr. Anton Berns (The
Netherlands Cancer Institute, Amsterdam, The Netherlands) (IL-1
 
a
 
)
or from Stratagene (129SvJ Mouse Genomic Library in the FIX
II Vector; La Jolla, CA) (IL-1
 
b
 
 and IL-1ra) using mouse cDNA
probes or a genomic DNA probe (see below), and were partially
sequenced before constructing targeting vectors. The neomycin
resistance gene (
 
neo
 
) (26) and hygromycin B phosphotransferase
gene (
 
hph
 
) (27) were used as positive selection markers in ES cells
under the control of the phosphoglycerate kinase (PGK) 1 pro-
moter. To monitor IL-1 gene expression, the 
 
b
 
-galactosidase
gene (
 
lacZ
 
) (Pharmacia Biotech, Inc., Piscataway, NJ) was inserted
in IL-1
 
a
 
 and IL-1
 
b
 
 genes to produce IL-1-LacZ fusion proteins.
For the IL-1
 
a
 
 targeting vector, a 1.5-kb DNA fragment be-
tween the Sau3AI and KpnI sites in exon 5 and intron 5, respec-
tively, including the NH
 
2
 
-terminal coding region for mature IL-1
 
a
 
,
was deleted, and the 
 
lacZ
 
-pA-PGK-
 
hph
 
-pA cassette was inserted
in place of the DNA fragment. A diphtheria toxin A fragment gene
under the control of the MC1 promoter (DT) (28) was ligated at
the 5
 
9
 
 end of the vector for negative selection (Fig. 1 
 
A
 
). Homol-
ogous regions of 5
 
9
 
 and 3
 
9
 
 ends were 1.5 and 5.5 kb, respectively.
For the IL-1
 
b
 
 targeting vector, a 2.45-kb DNA fragment be-
tween the HincII and BstXI sites in exons 3 and 5, respectively,
including the NH
 
2
 
-terminal coding region for mature IL-1
 
b
 
, was
deleted, and the 
 
lacZ
 
-pA-PGK-
 
neo
 
-pA cassette was inserted in
place of the DNA fragment (Fig. 1 
 
B
 
). Homologous regions of
the 5
 
9
 
 and 3
 
9
 
 ends were 1.5 and 3.9 kb, respectively.
To disrupt all three isoforms of the IL-1ra gene product, a
5.2-kb DNA fragment between the AvaI and SphI sites which
contains all the coding regions for the secreted form of the IL-1ra
was deleted, and the PGK-
 
neo
 
-pA cassette was inserted in place of
the DNA fragment. DT was ligated at the 5
 
9
 
 end of the vector for
negative selection (Fig. 1 
 
C
 
). Homologous regions of the 5
 
9
 
 and
3
 
9
 
 ends were 1.8 and 4.5 kb, respectively.
 
Production of IL-1
 
a
 
, IL-1
 
b
 
, and IL-1ra KO Mice.
 
ES cells (R1,
kindly obtained from Dr. Andras Nagy, Samuel Lunenfeld Re-
search Institute, Mount Sinai Hospital, Toronto, Canada) were
electroporated with 20–25 
 
m
 
g of a linearized IL-1
 
a
 
, IL-1
 
b
 
, or
IL-1ra targeting vector per 10
 
7 cells as described previously (29).
ES cells were then plated onto mitomycin C–treated NHL7 cells
(27) or G418-resistant primary embryonic fibroblast cells and se-
lected with hygromycin B (140 mg/ml; Calbiochem-Novabio-
chem Corp., La Jolla, CA) for IL-1a, or G418 (180–300 mg/ml;
GIBCO BRL, Gaithersburg, MD) for IL-1b and IL-1ra. Resis-
tant colonies were picked up 6–8 d after selection. Homologous
recombination was screened by PCR and confirmed by Southern
blot analysis using 59 and 39 probes. Chimera mice were pro-
duced by an aggregation method modified from the original re-
port (30). 10–15 ES cells were aggregated with two (C57BL/6 3
DBA/2)F1 eight-cell stage embryos in a hole on a plastic dish and
cultured overnight, and well-formed blastocysts were transferred
into the uterus of pseudopregnant female mice. Male chimera
mice were then bred with C57BL/6 female mice, and germline
transmission was checked by agouti coat color. Mice heterozy-
gous for IL-1a, IL-1b, or IL-1ra mutation were intercrossed to
yield homozygous mice for the mutation. 2Asano, M., R. Horai, and Y. Iwakura, manuscript in preparation.1465 Horai et al.
PCR primers were as follows: P1, 59-CTT GGC CAT ACT
GCA AAG GTC ATG-39; P2, 59-GAG GTG CTG TTT CTG
GTC TTC ACC-39; P3, 59-GCG AAT GTG TCA CTA TCT
GCC ACC-39; P4, 59-GCT GTG ATA GCA ACA GTT TGT
ACC-39; and P5, 59-GAC TGC CTT GGG AAA AGC GCC
TCC-39. The PCR reaction buffer contained 50 mM KCl, 10
mM Tris-HCl (pH 9.0), 0.1% Triton X-100, 1.5 mM MgCl2, 0.2
mM for each of the dNTPs, 1 mM primers, and 2.5 U/50 ml Taq
polymerase (Boehringer Mannheim Corp., Indianapolis, IN).
PCR cycles were 948C for 1 min, 668C for 2 min, and 728C for 3
min, over 40 cycles.
Mice were kept under specific pathogen–free conditions in an
environmentally controlled clean room at Laboratory Animal
Research Center, Institute of Medical Science, University of To-
kyo. All equipment and supplies, including cages, water bottles,
wooden chips, and food pellets, were sterilized. The experiments
were carried out according to institutional ethical guidelines for
animal experiments and safety guidelines for gene manipulation
experiments. Sex- and age-matched adult mice were used for
each experiment.
Southern Blot Hybridization Analysis. Genomic DNA was iso-
lated from ES cell clones and mouse tails. DNA (10 mg) digested
with an appropriate restriction enzyme was electrophoresed on a
0.7% agarose gel and transferred to a nylon membrane (Gene
Screen Plus; NEN Research Products, Boston, MA). Hybridiza-
tion was performed at 428C with 32P-labeled probes in a buffer
containing 53 SSCP (0.75 M NaCl, 75 mM sodium citrate, 50
mM NaH2PO4, 5 mM EDTA), 50% formamide, 23 Denhardt’s
solution, 1% SDS, and 100 mg/ml salmon testis DNA. Mem-
branes were washed in 23 SSC containing 1% SDS at room tem-
perature, and 0.13 SSC containing 1% SDS at 658C. Probes
were labeled with [32P]dCTP using a random priming method
Figure 1. Targeted disruption of the IL-1
gene family by homologous recombination.
Genomic loci, targeting vectors, and mu-
tated loci of IL-1a, IL-1b, and IL-1ra genes
are indicated. (A) Targeting strategy for the
IL-1a gene. A DNA fragment including
exon 5 was replaced with the lacZ-PGK-
hph-pA cassette (LacZ-hph). MC1-DT was
ligated at the 59 end of the vector for nega-
tive selection. (B) Targeting strategy for the
IL-1b gene. A DNA fragment including
exon 3–5 was replaced with the lacZ-PGK-
neo-pA cassette (LacZ-neo). (C) Targeting
strategy for the IL-1ra gene. A DNA frag-
ment containing all the coding regions for
the IL-1ra secretion form was replaced with
the PGK-neo-pA cassette (neo). DT was li-
gated at the 59 end of the vector for nega-
tive selection. Arrowheads, Primers (P1–P5)
used for PCR. Striped lines, Probes for
Southern blot analysis are indicated as 59
and 39 probes. Arrows, Expected sizes of
DNA fragments obtained by restriction en-
zyme digestions. Black boxes, Exons. White
boxes, Introns. Restriction enzyme sites are
also indicated in the maps. w.t., Wild-type.1466 Roles of IL-1 in Neuro-immuno-endocrine System
(Amersham Corp., Arlington Heights, IL). The NheI-SpeI frag-
ment was used as the 59 probe, and the SmaI-SmaI fragment was
used as the 39 probe to analyze the targeted IL-1a gene. In the
case of IL-1b, the XbaI-EcoRI fragment 59 upstream of the tar-
geting vector and the HindIII-HindIII fragment 39 downstream
of the vector were used as probes. The ScaI-HindIII fragment 59
upstream of the targeting vector was used for IL-1ra.
Northern Blot Hybridization Analysis. Total RNA was isolated
from peritoneal exudate cells (PEC) by an acid guanidinium thio-
cyanate-phenol-chloroform extraction method (31), and poly A1
RNA was purified using the QuickPrep Micro mRNA purifica-
tion kit (Pharmacia Biotech, Inc.). Total RNA or poly A1 RNA
was electrophoresed on a 1.2% denatured agarose gel and trans-
ferred to a nylon membrane. Hybridization was performed at
428C with 32P-labeled DNA probes in a buffer containing 50%
formamide, 50 mM Tris-HCl (pH 7.5), 1 M NaCl, 53 Den-
hardt’s solution, 10% dextran sulfate, 0.1% sodium diphosphate,
1% SDS, and 200 mg/ml salmon testis DNA, and membranes
were washed in 23 SSC containing 1% SDS at room tempera-
ture, and in 0.13 SSC containing 1% SDS at 658C. Radioactivi-
ties were measured using the BAS-2000 system (Fuji Photo Film
Co., Tokyo, Japan).
Probes. Mouse IL-1a and IL-1b cDNAs (32, 33) were kindly
given by Dr. Tetsuo Sudo (Toray Industry, Kanagawa, Japan),
mouse cyclooxygenase (COX) 1 and -2 cDNAs (34) were from
Dr. Shozo Yamamoto (Tokushima University School of Medi-
cine, Tokushima, Japan), mouse IL-6 and TNF-a cDNAs (35,
36) were from Dr. Takashi Yokota (Institute of Medical Science,
University of Tokyo, Tokyo, Japan), and mouse b-actin cDNA
(37) was from Dr. Tetsu Akiyama (Institute for Microbial Dis-
ease, Osaka University, Osaka, Japan). Mouse IL-1ra cDNA (38)
and mouse IL-1ra 523-bp genomic DNA (39) were amplified
from spleen and ES cells, respectively. The PCR primers used to
amplify mouse IL-1ra cDNA were 59-CCT CGG GAT GGA
AAT CTG CTG-39 and 59-AGG CCT CGG CAG TAC TAT
TGG-39, and to amplify mouse IL-1ra genomic DNA were 59-
GAC TCG GAG TAC CTG TCA TGC-39 and 59-GCT CTG
GAC ATA TGG CAT GTG-39. PCR cycles were 948C for 1
min, 608C for 2 min, and 728C for 3 min, over 40 cycles.
Isolation and Culture of Peritoneal Macrophages. PEC were re-
covered from mice 4 d after intraperitoneal injection of 2 ml of
2% thioglycollate broth (Nissui Pharmaceutical Co., Ltd., Tokyo,
Japan) and cultured in RPMI 1640 medium (GIBCO BRL) sup-
plemented with 10% FCS. After 106 PEC were allowed to adhere
to 60-mm dishes for several hours or overnight, they were incu-
bated in either the presence or absence of 10 mg/ml LPS.
Fever Induction and Body Temperature Measurement. Intraperi-
toneal body temperature of male mice was measured using an
electric thermometer and tips (ELAMSÒ system; BioMedic Data
System, Inc., Maywood, NJ) with an accuracy of 60.18C. Mice
were anesthetized with nembutal, and the tip was implanted into
their peritoneal cavity. Each animal was housed in a separate cage
and allowed to recover for 1 wk. Regular day–night body tem-
perature rhythm was monitored for another week before the ex-
periment. The room temperature was kept at 24 6 18C. Mice at
z3 mo of age were injected subcutaneously with 150 ml of tur-
pentine oil (Nakarai Tesque, Inc., Kyoto, Japan) into both hind-
limbs. Body temperature was measured at noon every day until
the mice returned to normal body temperature.
Corticosterone Measurement. For turpentine-induced HPA axis
activation, groups of five mice were injected with either saline or
100 ml of turpentine and decapitated at 2 and 8 h after administra-
tion. 20 ml of the serum was diluted to 1 ml with distilled water
and extracted with 4 ml diethyl ether. The extracts were radioim-
munoassayed using a specific antibody to corticosterone as de-
scribed previously (40). The relative cross-reactivities of antibod-
ies to testosterone, progesterone, and deoxycorticosterone were
,0.1, 4, and 10%, respectively. The lower limit of detection in
the serum was 10 ng/ml.
Statistical Analysis. Student’s t test was used for statistical eval-
uation of the results.
Results
Production of IL-1a, IL-1b, IL-1a/b, and IL-1ra KO
Mice. Genomic DNAs for mouse IL-1a, IL-1b, and IL-
1ra genes were isolated from 129 genomic phage libraries.
Since the mouse IL-1a genomic clones have not been re-
ported, we cloned them using mouse IL-1a cDNA as
probe. The resulting IL-1a gene clones covered 15 kb of
the gene, which contained homologous sequences corre-
sponding to exons 5–7 of the human IL-1a gene (41). We
also cloned 17 kb of the IL-1b gene (42) containing all the
exons (1–7), and 28 kb of the IL-1ra gene (39) containing
all the exons (1–4) of the secreted form of IL-1ra. Target-
ing vectors for the IL-1a, IL-1b, and IL-1ra genes were
constructed as described in Materials and Methods (Fig. 1).
ES cells were electroporated with each targeting vector,
and either hygromycin B (IL-1a) or G418 (IL-1b and IL-
1ra)–resistant colonies were selected and screened by PCR
for homologous recombination. ES clones targeted for
both IL-1a and IL-1b genes were obtained using IL-1b–
targeted ES cells by a successive introduction of the IL-1a
targeting vector.2 Homologous recombination was con-
Figure 2. Southern blot anal-
ysis of DNA from cloned ES
cells and from transgenic mouse
tails bred by heterozygous inter-
cross. Hybridization was carried
out using 59 probes of each gene
as shown in Fig. 1. All the bands
detected correspond to either
the wild-type (W) or mutant al-
lele (M), as expected from the
genome structure shown in Fig.
1 (arrows). (A) DNA from IL-1a KO ES cells digested with EcoRI. The number shows the ES clone number, and R1 shows the parental ES cells. (B)
DNA from IL-1b KO ES cells digested with KpnI. (C) DNA from IL-1ra KO offspring digested with BamHI. 1/1, 1/2, and 2/2, Expected geno-
types.1467 Horai et al.
firmed by Southern blot analysis. Genomic DNAs from
cloned ES cells (Fig. 2, A and B), or from transgenic off-
spring (Fig. 2 C) were isolated and digested with either
EcoRI (Fig. 2 A), KpnI (Fig. 2 B), or BamHI (Fig. 2 C)
and analyzed by Southern blot hybridization using 59, 39,
and neo or hph probes (Fig. 1). Hybridization with a 59
probe detected an expected band length of 4.7, 10, or 5.0
kb, corresponding to the wild-type alleles of the IL-1a, IL-
1b, or IL-1ra genes, respectively, as well as a 6.7-, 6.2-, or
7.0-kb DNA band corresponding to the mutant alleles, re-
spectively (Fig. 2). All the bands hybridized with the 39
probe as well as with the neo or hph probe were also of ex-
pected length (data not shown), indicating that one of the
wild-type alleles in the targeted ES clones was replaced cor-
rectly by the mutant gene. The targeting efficiency of the IL-
1a, IL-1b, and IL-1ra genes was 4/282 (1.4%), 1/501
(0.2%), and 3/462 (0.6%), respectively. Chimera mice were
produced from these targeted ES cell clones, and germline
transmission of the targeted gene was observed in three of
four clones (IL-1a), one of one clone (IL-1b), and two of
three clones (IL-1ra). IL-1a/b double-KO mice were also
obtained similarly.2
To confirm deficiency of these genes, peritoneal mac-
rophages were prepared from these KO mice, and expres-
sion of the IL-1 and IL-1ra genes after LPS stimulation was
examined by Northern blot hybridization analysis. No IL-
1a, IL-1b, or IL-1ra mRNA was detected in any of the IL-
1a, IL-1b, or IL-1ra KO mice, respectively, indicating
complete disruption of the IL-1 and IL-1ra genes (Fig. 3).
Deficiency was also confirmed in IL-1a/b double-KO
mice.2
We found that homozygous pups not only with the IL-
1a, IL-1b, or IL-1ra mutation but also those with the IL-
1a/b mutation were born in a Mendelian ratio, indicating
that IL-1 and IL-1ra are dispensable during mouse embryo-
genesis. Mutant mice homozygous for IL-1a and IL-1b, as
well as for IL-1a/b, were healthy and fertile in specific
pathogen–free conditions. Mutant mice homozygous for
IL-1ra also developed normally before weaning at 4 wk old
and were fertile. However, their growth became retarded
after 6–8 wk of age (Table 1). This abnormality was more
significant in older mice. On the other hand, neither
growth retardation nor acceleration was observed in IL-
1a/b KO mice (Table 2). These observations suggest a
beneficial role for IL-1ra in growth and homeostasis.
Mutual Induction of IL-1a and IL-1b In Vitro. Macrophages
are a major producer of inflammatory cytokines, including
IL-1, IL-6, and TNF-a. To examine the effects of IL-1 de-
ficiency on the induction of other cytokines, thioglycol-
late-activated macrophages were obtained from the perito-
neal cavity, and expression levels of various inflammatory
cytokine genes were measured by Northern blot hybridiza-
tion analysis at 0, 3, 6, and 12 h after stimulation with LPS
in vitro. Macrophages from IL-1a KO mice expressed only
half of the IL-1b mRNA compared with those from wild-
type mice (Fig. 4 A). Macrophages from IL-1b KO mice
also expressed a lower level of IL-1a mRNA (Fig. 4 B).
These results suggest that IL-1a can induce expression of
IL-1b, and vice versa. Expression levels of IL-1ra, IL-6,
and TNF-a were not affected significantly in these mice
(Fig. 4, C–E).
Failure of Febrile Response against Turpentine-induced Local
Inflammation in IL-1b but not IL-1a KO Mice. Fever devel-
opment is a systemic response that can be elicited by a mul-
titude of exogenous stimuli. IL-1a, IL-1b, TNF-a, and
Figure 3. Northern blot analysis of RNA from macrophages from IL-
1a ( A ), IL-1b ( B ), and IL-1ra (C) KO mice. Thioglycollate-induced
peritoneal macrophages were prepared from wild-type (1/1), heterozy-
gous (1/2), or homozygous (2/2) mice. RNA was isolated from the
macrophages after incubation with 10 mg/ml LPS for 12 h (A) or 6 h (B
and C). Total RNA (5–10 mg) was loaded on a denatured agarose gel and
hybridized with either an IL-1a, IL-1b, IL-1ra, or b-actin probe.
Table 1. Body Weight of Heterozygous (1/2) and Homozygous (2/2) Littermates of IL-1ra KO Mice
Age
Males Females
1/22 / 21 / 22 / 2
wk
4 14.3 6 2.1 (18) 14.4 6 2.4 (13) 13.3 6 1.7 (14) 12.4 6 1.8 (17)
6 23.0 6 2.8 (10) 20.2 6 2.3 (8)* 17.6 6 1.7 (10) 17.1 6 1.1 (13)
8 26.0 6 3.0 (10) 22.4 6 1.8 (5)* 19.6 6 1.6 (10) 18.3 6 1.3 (15)*
10 29.1 6 3.4 (14) 24.3 6 2.1 (7)‡ 21.2 6 0.8 (11) 19.4 6 1.7 (18)‡
12 31.6 6 1.6 (6) 25.4 6 1.3 (10)‡ 22.0 6 0.9 (7) 19.1 6 2.4 (14)‡
The numbers in parentheses show the number of mice used in this experiment. *P ,0.05, ‡P ,0.01.1468 Roles of IL-1 in Neuro-immuno-endocrine System
IL-6 have been suggested as putative endogenous pyrogens
(13). Subcutaneous injection with turpentine in the hind-
limbs of mice causes local inflammation and induces fever.
We examined the role of IL-1 in the turpentine-induced
fever model using IL-1a/b KO mice. As shown in Fig. 5
A, febrile response in IL-1a/b KO mice was reduced sig-
nificantly compared with wild-type mice, suggesting that
either IL-1a or IL-1b, or both, is important for fever in-
duction. Then, to discriminate the roles for IL-1a and IL-1b,
IL-1a and IL-1b KO mice were examined. In IL-1b KO
mice, body temperature did not rise significantly after tur-
pentine treatment, in contrast to the turpentine-injected
control mice (Fig. 5 B). However, in IL-1a KO mice, body
temperature rose as in control mice from day 1 to day 5 af-
ter the injection, and returned to normal by day 6 (Fig. 5 B).
These results were confirmed in another experiment.
These observations indicate a critical role for IL-1b but not
IL-1a in the febrile response to local inflammation.
On the other hand, body temperature changes in IL-1ra
KO mice were significantly greater than those in turpen-
tine-injected control mice on day 1 (P ,0.01) (Fig. 5 C).
Body temperature in IL-1ra KO mice did not return to
normal circadian temperature even 1 wk after turpentine
injection (Fig. 5 C). These results suggest a regulatory
function for IL-1ra in the febrile response.
Suppression of IL-1a Expression in the Brain of IL-1b KO
Mice, but Less Marked Suppression of IL-1b Expression in IL-1a
KO Mice, after Treatment with Turpentine. We examined the
effects of IL-1 and IL-1ra deficiency on the expression of
related genes in the brain after turpentine injection, in or-
der to ascertain why IL-1b but not IL-1a deficiency causes
suppression of fever development by this reagent. In wild-
type mice, induction of both IL-1a and IL-1b mRNA was
observed as early as 6 h after turpentine treatment and
reached a peak at 12 h, coincident with the development of
fever (Fig. 6 A). Both mRNA levels were comparable,
ranging 10–20-fold higher than in untreated control mice.
Since both IL-1a and IL-1b can induce febrile response,
these results indicate that the reason why IL-1a deficiency
does not affect fever induction is not due to the inability of
Table 2. Body Weight of Control (1/1, 1/2) and Homozygous (2/2) Littermates of IL-1a/b KO Mice
Age
Males Females
1/1,1/22 / 21 / 1 , 1 / 22 / 2
wk
4 15.8 6 2.3 (24) 15.3 6 1.5 (17) 15.1 6 1.9 (9) 13.5 6 2.4 (19)
8 25.3 6 2.8 (15) 24.7 6 2.2 (9) ND ND
10 28.3 6 2.9 (12) 27.1 6 2.2 (28) ND ND
12 28.4 6 3.3 (34) 27.6 6 2.9 (27) 22.0 6 2.1 (17) 21.0 6 3.2 (21)
The numbers in parentheses show the number of mice used in this experiment.
Figure 4. Expression of inflammatory cytokine genes in peritoneal
macrophages from IL-1a and IL-1b KO mice. Thioglycollate-induced
peritoneal macrophages were prepared from wild-type (open triangles) and
homozygous IL-1a (filled circles) and IL-1b (filled squares) KO mice. Mac-
rophages were treated with 10 mg/ml LPS for 0, 3, 6, and 12 h, and the
total RNA was isolated. Northern blot analysis was carried out using each
cytokine probe and a b-actin probe. Relative radioactivity of each cyto-
kine mRNA was calculated as a percentage of b-actin mRNA. (A) IL-
1a; (B) IL-1b; (C) IL-1ra; (D) IL-6; and (E) TNF-a mRNA. The values
represent the mean 6 SD of three independent experiments.1469 Horai et al.
turpentine to induce IL-1a in the brain. Interestingly, we
found that IL-1a mRNA expression is hardly detected in
IL-1b KO mice, suppressed .30-fold compared with
wild-type mice (Fig. 6 A). However, IL-1b mRNA could
still be detected in IL-1a KO mice, although the expres-
sion was 10-fold lower than in control mice. These obser-
vations were confirmed in two other experiments. Thus, it
was shown that IL-1b deficiency abrogated not only IL-1b
but also IL-1a expression in the brain, and that IL-1a defi-
ciency did not suppress expression of IL-1b completely. Figure 5. Fever induction after turpentine injection. Wild-type mice
(Cont.) and homozygous IL-1 KO mice (KO) (male) were implanted
with transmitters to monitor body temperature. Mice were injected sub-
cutaneously with either saline (Sal.) or turpentine oil (Tur.) in both hind-
limbs. Fever development was monitored in IL-1a/b (A), IL-1a and IL-
1b (B), and IL-1ra (C) KO mice. Arrowheads, Time point of turpentine
injection. The number of mice used for each experiment is shown in pa-
rentheses. Fever development was compared between these KO mice and
wild-type mice injected with turpentine. *P ,0.001, ‡P ,0.01, §P ,0.05.
These experiments were repeated twice with similar results.
Figure 6. Time course of mRNA expression specific for the IL-1a, IL-
1b, COX-1, and COX-2 genes in whole brain after turpentine injection.
Wild-type (1/1) or homozygous (2/2) mice were injected with 100 ml
turpentine subcutaneously in the left hindlimb. Mice were killed at 0, 6,
12, and 24 h after turpentine injection, and poly A1 RNA was isolated
from whole brain. Poly A1 RNA (5–10 mg) was electrophoresed on a de-
natured agarose gel and hybridized with specific probes. b-actin was used
as a control. (A) IL-1a and IL-1b KO mice; (B) IL-1ra and IL-1a/b KO
mice.1470 Roles of IL-1 in Neuro-immuno-endocrine System
IL-1b mRNA expression in IL-1ra KO mice was aug-
mented 2.5-fold compared with wild-type mice 12 h after
injection with turpentine, whereas IL-1a mRNA expres-
sion was not affected (Fig. 6 B). These results were consis-
tent with enhanced febrile response in IL-1ra KO mice
(Fig. 5 C). As expected, neither the IL-1a nor IL-1b
mRNA was detected in IL-1a/b double-KO mice (Fig. 6 B).
To correlate IL-1 expression with fever development,
the expression levels of IL-1a and IL-1b mRNA in spe-
cific regions in the brain after turpentine injection were ex-
amined by Northern blot hybridization analysis. Intense
expression of both IL-1a and IL-1b mRNA was observed
in the cerebral cortex and diencephalon in wild-type mice,
whereas expression levels were low in the hippocampus
and cerebellum (Fig. 7 A). The expression level of IL-1b in
the diencephalon, where body temperature is thought to
be controlled, was 1.5-fold lower in IL-1a KO mice,
whereas IL-1a as well as IL-1b mRNA could not be de-
tected in IL-1b KO mice, indicating that IL-1a expression
was .30-fold lower than in wild-type mice (Fig. 7 A).
These data are consistent with the data shown in Fig. 6 A,
in which whole brain was used for the analysis, although
the effect of IL-1a deficiency on IL-1b expression is less
marked in the diencephalon than in the whole brain. We
confirmed these results in two independent experiments.
These results indicate that the expression of the IL-1a gene
in the diencephalon is dependent mostly on the expression
of IL-1b, and that IL-1b expression is relatively indepen-
dent of IL-1a expression.
The expression level of IL-1ra mRNA in the diencepha-
lon of IL-1a KO mice was similar to that in wild-type
mice (Fig. 7 A). In contrast, the IL-1ra expression level was
much reduced (,1/10 of the wild-type level) in IL-1b KO
mice (Fig. 7 A). IL-1a and IL-1b mRNA expression levels
in the diencephalon of IL-1ra KO mice were 1.5- and 2-fold
higher than those of wild-type mice (Fig. 7 B). These re-
sults suggest the possibility that IL-1ra functions as a sup-
presser of IL-1 expression under stress.
Induction of COX-2 but not COX-1 by IL-1 in the
Brain. IL-1 is known to induce transcription of the
COX-2 gene (43), an enzyme that catalyzes synthesis of
prostaglandins, including prostaglandin E2 (PGE2). Since
PGE2 is a potent mediator of the febrile reaction in the
body (13), COX-2 expression during turpentine-induced
fever was examined. As shown in Fig. 6 A, expression of
the COX-2 but not the COX-1 gene was induced three-
fold in the brain after treatment with turpentine, coinci-
dent with peak expression of IL-1 at 12 h. This induction
was also observed in IL-1a KO mice, although the level
was slightly lower than in wild-type mice. In contrast, in-
duction of COX-2 expression in the brain after treatment
with turpentine was not observed in IL-1b KO mice, indi-
cating that IL-1b is the major mediator of COX-2 induc-
tion (Fig. 6 A).
Figure 7. Region specificity of mRNA expression in the brain at 12 h
after turpentine injection. Samples were pooled from four mice of each
genotype. Lane 1, Cerebral cortex; lane 2, diencephalon; lane 3, hippo-
campus; lane 4, cerebellum. Poly A1 RNA (5–10 mg) was purified from
each part of the brain and hybridized with probes as indicated. (A) IL-1a
and IL-1b KO mice; (B) IL-1ra and IL-1a/b KO mice.
Figure 8. Turpentine-induced
serum corticosterone levels in
IL-1a/b KO mice. Control
(Cont) and IL-1a/b KO mice
were injected subcutaneously
with saline (white bars) or turpen-
tine (black bars), and serum sam-
ples (n 5 5) were obtained at 2 h
(A) and 8 h later (B). Cortico-
sterone levels were then mea-
sured by radioimmunoassay. Al-
though corticosterone levels at
2 h were similar, the levels at 8 h
were significantly higher in wild-
type than in IL-1a/b KO mice.
*P ,0.01.1471 Horai et al.
COX-2 expression in IL-1ra KO mice was 1.5-fold
higher at 12 h compared with wild-type mice, correlating
with the augmented expression of IL-1b in these mice,
whereas COX-1 expression level was not affected (Fig. 6
B). These results suggest that COX-2 expression level is
controlled by a balance between IL-1 and IL-1ra.
COX-2 expression in the diencephalon was not induced
in IL-1b KO mice after treatment with turpentine, whereas
its expression was induced similarly in IL-1a KO as in
wild-type mice (Fig. 7 A). COX-2 expression was 2.5-fold
higher in IL-1ra KO compared with wild-type mice (Fig. 7
B). In these KO mice, the mRNA expression level of
TNF-a, a possible mediator of fever development in the
brain, was not affected (Fig. 7 A). These data show that
COX-2 is induced mainly by IL-1b, and that this induc-
tion is antagonized by IL-1ra.
Suppression of HPA Axis Activation in IL-1 KO Mice.
Acute inflammatory stimuli are known to elevate circulat-
ing corticosterone levels through activation of the HPA
axis. To further elucidate the roles of IL-1 in the neuro-
immuno-endocrine system, we examined the effects of IL-1
as well as IL-1ra deficiency on serum corticosterone levels
after treatment with turpentine.
When mice were treated with turpentine, serum corti-
costerone levels increased two- to fourfold at 2 h after in-
jection. At this point, the induction level did not differ be-
tween IL-1a/b KO and wild-type mice (Fig. 8 A).
However, at 8 h after turpentine injection, the level was
significantly lower in IL-1a/b KO compared with wild-
type mice, in which the level was elevated three- to five-
fold (Fig. 8 B; P ,0.01).
Then, to discriminate molecular species of IL-1 in-
volved, IL-1a and IL-1b KO mice were injected with tur-
pentine, and the serum corticosterone level at 8 h was mea-
sured. As shown in Fig. 9, A and B, the serum corticosterone
level in IL-1b KO mice was not elevated (P ,0.001),
whereas corticosterone levels in IL-1a KO mice were ele-
vated similarly to that in control mice. These data clearly
show that IL-1 is not responsible for turpentine-induced
activation of the HPA axis at the initial phase but is respon-
sible for the secondary rise of corticosterone, and that IL-1b
but not IL-1a is a major mediator of this activation.
The effects of IL-1ra deficiency were also examined. As
shown in Fig. 9 C, corticosterone levels in IL-1ra KO mice
at 8 h after turpentine injection were elevated similarly to
heterozygous control mice. Thus, IL-1ra did not seem nec-
essary for the regulation of serum corticosterone level after
treatment with turpentine.
Discussion
Production of IL-1a, IL-1b, IL-1a/b, and IL-1ra KO
Mice. Although mice deficient in either IL-1b, IL-1ra, or
IL-1RI have been produced previously (17, 44–46), to our
knowledge, IL-1a and IL-1a/b double-KO mice have not
yet been available. Since IL-1a and IL-1b have similar bio-
logical activities, and since both molecules can bind with
both IL-1RI and IL-1RII, the effects of IL-1 deficiency
could only be observed in IL-1a/b double-KO mice. In
this report, to ascertain the pathophysiological roles of IL-1
in normal physiology and under stress, we first produced
both IL-1a KO and IL-1a/b double-KO mice, together
with IL-1b and IL-1ra KO mice, and then compared the
phenotypes of these KO mice with each other.
All of these KO mice were fertile, and the pups were
born healthy, indicating that IL-1 is not necessary for em-
bryogenesis and reproduction, although previous studies
suggested the importance of IL-1 in gonadotropin release,
oogenesis, testosterone synthesis, and maintenance of preg-
nancy (47, 48). After birth, IL-1a/b as well as IL-1a and
IL-1b KO mice developed normally. In contrast, the
growth after weaning was retarded in IL-1ra KO mice,
consistent with a previous report (45). We found that the
growth retardation was first observed between 6 and 8 wk
of age, later becoming increasingly obvious. Since some
cytokines, including IL-1 and TNF-a, induce anorexia
(49, 50), the defect observed in IL-1ra KO mice could be
due to appetite suppression caused by IL-1 overproduction
in the satiety center in the brain. However, it should be
noted that the growth of IL-1a/b KO mice was not accel-
erated compared with their wild-type or heterozygous lit-
termates. These observations suggest that the low level of
IL-1 detected in untreated wild-type mice is not inhibitory
for body growth, provided that IL-1ra is present, and only
higher levels of IL-1, or lack of IL-1ra, or both, causes sup-
pression. However, it is also possible that IL-1ra may antag-
onize the binding of molecules other than IL-1 that exert
Figure 9. Turpentine-induced
serum corticosterone levels in
IL-1a (A), IL-1b (B), and IL-1ra
(C) KO mice. IL-1a KO (a
KO), IL-1b KO (b KO), and
IL-1ra KO (ra KO) mice were
injected subcutaneously with sa-
line (white bars) or turpentine
(black bars), and serum samples (n
5 5, except for saline-injected
IL-1a KO mice) were obtained
8 h later. The corticosterone
level in IL-1a or IL-1ra KO
mice is similar to that in wild-
type mice, whereas that in IL-1b
KO mice is significantly lower. *P
,0.001.1472 Roles of IL-1 in Neuro-immuno-endocrine System
suppressive effects on body growth, or it may directly pro-
mote body growth.
Mutual Induction between IL-1a and IL-1b. We showed
that IL-1b mRNA levels in IL-1a KO macrophages after
treatment with LPS were two- to threefold lower than in
wild-type macrophages, and that IL-1b deficiency also
caused a similar reduction in IL-1a expression. In agree-
ment with our results, Fantuzzi et al. also reported that
IL-1a protein production in IL-1b–deficient macrophages
was approximately half that of wild-type macrophages after
stimulation with LPS in vitro (51). The finding that IL-1a
production in macrophages from IL-1b converting enzyme
KO mice, in which mature IL-1b could not be produced,
was about fivefold lower than in wild-type macrophages is
also consistent with our results (52). These results suggest
that IL-1 is involved in the induction of IL-1. In agreement
with this notion, it was reported previously that both IL-1a
and IL-1b were induced by recombinant IL-1a in vivo
and in vitro (53). In contrast to these observations, Shor-
nick et al. reported that IL-1a mRNA level was not af-
fected by IL-1b deficiency in LPS-treated macrophages
(44). Although the reason for this discrepancy is not clear at
present, it is possible that the difference in LPS concentra-
tions for macrophage stimulation may affect the results.
Another possibility is that a mutant product which still has
the ability to induce IL-1a might be produced in their
studies, since their targeting construct contained only an in-
sertional mutation in exon 4, in contrast to Zheng et al. (17)
and our constructs, in which functional exons were deleted.
The expression level of IL-1ra and TNF-a was not affected
significantly in IL-1a and IL-1b KO mice, suggesting that
these cytokines are regulated independently of IL-1. Al-
though the expression level of IL-6 in IL-1b KO mice
seemed greater than in IL-1a KO mice at 6 h after LPS
stimulation, the difference was not statistically significant.
In contrast to the effects of IL-1a or IL-1b deficiency on
the production of IL-1 in vitro, the effects were much
more marked in the brain; IL-1a mRNA was reduced
.30-fold in IL-1b KO mouse brain after induction with
turpentine compared with wild-type mouse brain, and IL-
1b mRNA levels were reduced 5- to 10-fold in IL-1a KO
mice. It was remarkable that IL-1a induction in the brain
was much more dependent on the presence of IL-1b than
IL-1b induction was dependent on IL-1a. The mechanism
that activates both IL-1a and IL-1b genes through a single
IL-1 receptor is considered to be an efficient way of ampli-
fying the IL-1 signal. We reported previously that mutual
induction was also observed between IFN-a and IFN-b,
both of which bind to the same receptor (54). Thus, the
presence of two homologous genes with similar biological
activity and the same receptor specificity seems to be one
of the widely used mechanisms for cells to amplify the re-
sponse against weak stimuli. The data presented in this pa-
per show that this mechanism plays an important role in
the induction of IL-1 in the brain.
The expression level of IL-1ra was reduced markedly in
IL-1b KO mouse brain. This observation is consistent with
reports that IL-1b is a potential inducer of IL-1ra (55, 56),
and suggests a feedback mechanism of IL-1 activity.
Recently, it was reported that insertion of the neo gene
into the host chromosome might disturb the expression of
neighboring genes (57). Therefore, it is possible that the
observed suppressive effect of IL-1a and IL-1b deficiency
on the expression of the other molecule may be the result
of neo or hph gene insertion into these loci, which are only
50 kb apart on chromosome 2. However, it seems unlikely
that independent insertional events of different genes into
different loci, that is, insertion of the lacZ-hph gene into the
IL-1a gene or of the lacZ-neo gene into the IL-1b gene,
can cause similar suppression on both genes. Furthermore,
since suppression of IL-1a production has also been re-
ported in IL-1b–converting enzyme KO mice, in which
insertion of the neo gene occurred in a totally different lo-
cus (chromosome 9), we believe that mutual induction of
IL-1a and IL-1b is not an artificial result caused by trans-
gene insertion but rather a characteristic of these genes.
Role of IL-1 in Turpentine-induced Fever. Subcutaneous in-
jection of turpentine causes local inflammation and induces
fever. It is known that the hypothalamus is involved in
temperature control (58). This study showed that fever de-
velopment was not induced in IL-1a/b KO mice, indicat-
ing that IL-1 is involved in fever induction. We also found
that this fever induction was abolished in IL-1b but not IL-
1a KO mice. Involvement of IL-1b in turpentine-induced
fever has also been reported by Zheng et al. using IL-1b
KO mice (17). These observations do not necessarily imply
that the fever induction is caused mainly by IL-1b, since
IL-1a as well can cause a febrile reaction in mice (16), and
both IL-1a and IL-1b are induced in turpentine-treated
mice (Fig. 6). These results indicate that IL-1a deficiency
in the febrile reaction can be compensated for with IL-1b,
but IL-1b deficiency cannot be compensated for. To ex-
plain this, we found that significant levels of IL-1b expres-
sion were still observed in the brains of IL-1a KO mice af-
ter treatment with turpentine, although the level was 1/5–
1/10 that in wild-type mice. Further, IL-1a expression in
IL-1b KO mice was ,1/30 that in wild-type mice and
thus hardly detectable. These data indicate that the IL-1b
gene is crucial for febrile response, and that the absence of
both IL-1a and IL-1b expression in IL-1b KO mice is the
reason why febrile response is abolished in IL-1b KO mice.
Consistent with these observations, we found that febrile
response was enhanced in IL-1ra KO mice associated with
enhanced expression of IL-1b. However, it is possible that
IL-1 signaling is enhanced due to the absence of the com-
petitor molecule in IL-1ra KO mice. Although we failed to
detect IL-6 mRNA in the brain after turpentine injection
by Northern blot analysis (data not shown), it is most likely
that IL-6 is a major mediator downstream of IL-1b in this
fever development, since central injection of LPS or IL-1b
could not elicit a fever response in IL-6 KO mice (18, 59).
It is known that IL-1 induces COX-2 in the brain (60).
We found that induction of COX-2 was greatly suppressed
in the brain of IL-1b as well as IL-1a/b KO mice, but1473 Horai et al.
COX-1 expression was not affected in these KO mice. It is
noteworthy that the suppression of COX-2 induction was
especially prominent in the diencephalon, whereas expres-
sion in the cerebral cortex and hippocampus was minimally
affected. Since expression of IL-1 was observed both in the
cortex and diencephalon, these observations indicate re-
gion-specific control of COX-2 by IL-1 in the brain: the
expression in the diencephalon is dependent on IL-1,
whereas the expression is independent of IL-1 in other
brain regions. Although the mechanism for the region-spe-
cific induction of COX-2 by IL-1 remains to be eluci-
dated, these results suggest a complex regulatory mecha-
nism for COX-2 expression. The regulatory role of IL-1 in
COX-2 expression in the diencephalon was also suggested
by the fact that COX-2 expression in the diencephalon was
enhanced in IL-1ra KO mice. These observations are con-
sistent with the notion that the absence of COX-2 induc-
tion in the diencephalon is responsible for the defect in fe-
brile response in IL-1 KO mice.
Role of IL-1 in the HPA Axis-mediated Stress Response.
It is well known that corticosterone secretion from the ad-
renal gland is controlled by ACTH released from the pitu-
itary, and ACTH by CRH from the hypothalamus. Since
previous studies suggested involvement of IL-1 in the regu-
lation of CRH secretion from the hypothalamus (61, 62),
we examined glucocorticoid levels after induction with
turpentine in IL-1 KO mice. We found that the cortico-
sterone level in the serum of IL-1a/b KO mice was signif-
icantly low at 8 h after turpentine injection, although corti-
costerone was induced similarly in KO mice as in wild-type
mice at 2 h after the injection (Fig. 8). These results suggest
two different mechanisms in the activation of the HPA axis
after treatment with turpentine. The initial rise in gluco-
corticoid secretion seems to be caused by direct activation
of the hypothalamus either through neurological pathways
or through other cytokines than IL-1 induced by turpen-
tine. On the other hand, the second rise is thought to be
mediated by the increase of IL-1 in the brain. This second
rise in corticosterone level was also suppressed in IL-1b
KO mice, but not in IL-1a KO mice. This indicates that
deficiency of IL-1a in activating the HPA axis can also be
compensated for with IL-1b, as in the febrile response.
However, IL-1b deficiency cannot be compensated for, prob-
ably because of the strong suppression of IL-1a expression
in IL-1b KO mice. Although Fantuzzi and Dinarello re-
ported that corticosterone levels were not affected by IL-1b
deficiency, this is not inconsistent with our results, since
they only examined levels 2 h after treatment with turpen-
tine (25).
In summary, the results presented in this report indicate
importance of IL-1 in maintaining homeostasis of the body
by controlling fever development and glucocorticoid syn-
thesis. We suggest that a network formed by IL-1a, IL-1b,
and IL-1ra regulates the expression of these molecules with
each other, and this may contribute an efficient response to
inflammation or infection. These KO mice should be use-
ful to investigate further the roles of IL-1 in normal physi-
ology and under stress.
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